COVID-19: how can travel medicine benefit from tourism’s focus on people during a pandemic?

• Published in: Tropical Diseases, Travel Medicine and Vaccines
• Main Author: Irmgard L. Bauer
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMC 2022
• Subjects: SARS-CoV-2; Risk Perception; Mass Gatherings; Tourism Employees; Discrimination; Infectious Diseases; Arctic medicine. Tropical medicine; RC955-962; Arctic
• Online Access: https://doi.org/10.1186/s40794-022-00182-6; https://doaj.org/article/ddae95f7c3b64d078582ccbc5952040b

Abstract In 2020, COVID-19 affected every aspect of life around the globe. The spread of SARS-CoV-2 through travel led to lockdowns, travel bans and border closures, crippling the tourism industry. Without tourists, there would be no tourism industry—and no travel medicine. Therefore, scholars started to research the human aspect of tourism immediately to develop strategies for economic recovery. The resulting insights are useful for travel medicine not only to see how tourism dealt with a medical crisis but also to understand travellers better who may be seeking health advice during and after a pandemic. This article presents tourism research of 2020 covering risk perception and travel intentions including mass-gatherings, the use of technology to protect from infection, impacts on tourism workers, residents’ reactions to potentially infected travellers, discrimination, and racism. A potential fork in the road to tourism’s future may have implications for travel health practitioners. Research recommendations conclude the paper. Understanding the industry response during the early days of panic and uncertainty may help prepare not only appropriate guidelines for travellers but also clearer instructions for tourism, transportation, and hospitality in anticipation of the next pandemic.